Table 3.

Incidence of AEs after any vaccination.

AE category, n (%) a	Adjuvanted HAI-05			Unadjuvanted HAI-05		Placebo
	15 µg	45 µg	90 µg	90 µg
	N = 18	N = 20	N = 20	N = 20		N = 22
Any AEs	9 (50)	8 (40)	13 (65)	10 (50)		11 (50)
Treatment-related AEs	2 (11.1)	0	4 (20)	1 (5)		0
Serious AEs	0	0	0	0		0
AEs leading to discontinuation from the study	0	0	0	0		0
AEs leading to death	0	0	0	0		0

^a: Number (%) of subjects reporting symptom at any post-vaccination assessment. Each subject was counted only once.